Bleeding risk of Glycoprotein (GP) IIb IIIa inhibitors or thienopyridines with fondaparinux vs. enoxaparin in Acute Coronary Syndromes: insights from the OASIS 5 trial

Journal Article (Journal)

Full Text

Duke Authors

Cited Authors

  • Jolly, S; Mehta, SR; Widimsky, P; Afzal, R; Steg, PG; Valentin, V; Budaj, A; Fox, KAA; Granger, CB; Yusuf, S

Published Date

  • September 1, 2007

Published In

Volume / Issue

  • 28 /

Start / End Page

  • 516 - 516

Published By


  • 1

International Standard Serial Number (ISSN)

  • 0195-668X


  • English